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ABSTRACT
COMPARISON OF LONGITUDINAL CHANGES IN RESTING STATE
FUNCTIONAL MAGNETIC RESONANCE IMAGING BETWEEN
ALZHEIMER’S PATIENTS AND HEALTHY CONTROLS
by
Berk Can Yilmaz
Resting State Functional Magnetic Resonance Imaging (rs-fMRI) is a technique that is
widely used for analyzing brain function using different approaches and methods. This
study involves rs-fMRI analysis of Blood Oxygenation Level Dependent (BOLD)
signals acquired from Alzheimer’s disease (AD) Patients and Healthy Controls (HC).
Each subject in the study had both functional and anatomical images with at least one
rs-fMRI scan with their Anatomical (T1) scans. Previous rs-fMRI studies have
demonstrated that AD shows differences in Amplitude of Low Frequency (<0.1 Hz)
Fluctuations (ALFF), and Regional Homogeneity (ReHo) measures according to HCs.
The aim of the study is to investigate individual and group level differences
using ReHo and mALFF related measures in a longitudinal analysis. The hypothesis is
that with the age and group (AD or HC) of the subject, it is possible to separate AD and
HC subjects from each other using 3 different ROIs (DMN – MT – MV), These regions
are known to show abnormalities in AD patients but clinical wise never been identified
as neuroimaging biomarkers. This study tries to check these ROIs to see if there are
significant differences between the AD patients and HCs using 3 different features.
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CHAPTER 1
INTRODUCTION

1.1 Alzheimer’s Disease
This current study focuses on functional brain activity in Alzheimer’s disease (AD) patients
and compares against healthy control subjects. AD, discovered and named after German
psychiatrist Dr. Alois Alzheimer, is a progressive neurodegenerative disease that affects older
people (>50 years old). His patient, Auguste D., experienced memory loss, paranoia,
psychological changes, and cognitive impairment. During the autopsy, Dr. Alzheimer found
abnormalities in the white matter (WM) of the AD patient’s brain (Azeez & Biswal, 2017,
Hippius & Neundörfer, 2003, Giffard et al., 2008). Figure 1 presents a representation of the
known risk factors associated with AD.

Figure 1.1 Alzheimer’s disease risk factors.
1

AD patients experience psychiatric symptoms and dementia that gradually progress with age
(Onyike, 2017), as represented in Figure 1.2. A recent study by Xia-a Bi and colleagues showed
that the number of AD patients worldwide could potentially reach one hundred million by 2050
(Bi et al., 2018). This necessitates the importance of having an early detection mechanism.
Biomarkers in neuroimaging provide the opportunity to improve early detection by identifying
changes that occur with the progression of psychiatric symptoms and dementia (Onyike, 2017).
For AD specifically, early detection can be improved by identifying changes in cognitive
function with neuroimaging.

Figure 1.2 Natural history of Alzheimer’s disease. Adapted from Feldman and Gracon, 1996.

Using neuroimaging to compare differences in cognitive function between AD patients and
healthy individuals provides the opportunity to better understand the progression of the disease.
Neuroimaging for AD also provides the opportunity to improve early detection based on
identified differences between AD patients and healthy individuals.
2

Figure 1.3 Three stage progress of Alzheimer’s disease.

Currently, various methods in neuroimaging are being used for the detection of AD. Positron
emission tomography (PET), magnetic resonance imaging (MRI), and functional MRI (fMRI)
are common neuroimaging methods that have been widely used to study AD. PET is a
neuroimaging method used for detecting changes in metabolic activity in the brain. The
disadvantages of the PET technique include its use of radioactive substances and its low spatial
and temporal resolution.
MRI is a neuroimaging method used to generate images of organs in the body. MRI
uses protons and electromagnetic waves to obtain images with high spatial resolution. MRI
does not have any known side effects and is therefore widely used in clinical imaging. The
fMRI method is a dynamic version of MRI and is widely used to study human brain function.
Some of the advantages of fMRI include the use of non-ionizing radiation, the ability to be noninvasive, the capacity to efficiently scan a single patient multiple times, and adequate spatial
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and temporal resolution (Bi et al., 2018, Tepmongkol et al., 2019, Giffard et al., 2008, Li et al.,
2002).
Resting-state functional magnetic resonance imaging (rs-fMRI) is becoming more popular
in the field of neuroimaging. For patients with AD, rs-fMRI is emerging as a standardized
method which allows for the measurement of functional connectivity in the brain. The use of
rs-fMRI suggests that data or model-driven methods can enable researchers to discern the
decline of brain function. More information regarding fMRI is discussed in Chapter 2.

1.2 Biomarkers
Biomarkers, first created for chronic pain disorders, are measurable parameters that can be used
to reliably identify disorders. Examples of biomarkers used today include prognostic and
predictive markers which, as the name suggests, can determine the risk of future pain and
ascertain the effects of treatment (van der Miesen et al., 2019, Woo & Wagner, 2015).
Neuroimaging biomarkers have certain features that can classify biomarkers as functional or
not. In the field of AD, technological advances have been made in identifying biomarkers by
using neuroimaging approaches to recognize changes that are associated with the progression
of the disease, especially in the frontal gyrus (FG) and the default mode network (DMN). In
AD patients, functional connectivity between the FG and other brain regions appear abnormal,
which may explain memory dysfunction and allow FG to be a potential biomarker for AD (Bi
et al., 2018). Suitable biomarkers must provide reliable information about the condition of the
living organism, and effective biomarkers are those that can allow us to better understand a
condition. This means that a biomarker should have distinguishable parameter(s) that are able
to identify significant differences and distinct conditions. A quality biomarker should offer
accurate diagnostic performance in classification or prediction of the condition, which is
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accomplished based on the sensitivity of the technique (Damoiseaux, 2012, Woo et al., 2017,
Woo & Wagner, 2015).

1.3 Objectives
The objective of this study is to see if the progression of Alzheimer‘s disease can be explained
by applying a multiple linear regression analysis using the information from ReHo and RSFC
spatial maps, and determine if this information can be used for early detection for this disease.
Altered brain regions in AD patients were determined by using several complimentary
approaches such as independent component analysis (ICA), regional homogeneity (ReHo), and
amplitude of low-frequency fluctuations (ALFF). Spatial maps, generated from rs-fMRI scans
of AD patients and HCs and analyzed using a multiple linear regression analysis, are to be used
to compare the two groups in a longitudinal approach. In this study, three regions were selected
to be used in multiple analysis techniques using age and condition (HC or AD) to separate the
two groups and identify the progression of the disease. Chapter 4 explains the various analysis
methods used for this study in more detail.

1.4 Outline
The outline of this thesis is presented as follows: Chapter 1 – Introduction, Chapter 2 – Magnetic
Resonance Imaging and Data Acquisition, Chapter 3 – Image Processing Methods, Chapter 4
– Functional Connectivity and Statistical Analysis, Chapter 5 – Results, Chapter 6 – Conclusion
and Discussion.
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CHAPTER 2
MAGNETIC RESONANCE IMAGE SCANNING AND DATA ACQUISITION

2.1 Magnetic Resonance Imaging Techniques
2.1.1 Magnetic Resonance Imaging Review
Magnetic Resonance Imaging (MRI) uses large magnetic fields with radiofrequency signals in
conjunction with hydrogen protons in our body to create high resolution structural images of
soft tissue. MRI has been used to study structural brain differences between healthy controls
and diseased patients, such as AD patients. fMRI has been used during both stimulus/task
activation and during the resting state condition to study systems-level human brain function.
In this section, MRI and functional MRI will be introduced to provide a background for the
techniques used in this study.
MRI uses strong magnetic fields in conjunction with radiofrequency signals at preset
frequencies (Larmor Frequency) to generate images. The generated magnetic field strengths are
typically represented in tesla (T), where one tesla equals 10,000 gausses. Although 3T machines
are widely used for human research, there are also 1.5T, 7T, and 11T MRI scanners available.
An MRI scanner has three main components, each represented by a letter in the MRI acronym.
The letter M in MRI stands for magnetic fields, which are typically generated by
superconducting coils within the machine. The magnetic field is responsible for stimulating
hydrogen protons or spin vectors. Stimulated spin vectors all align in the same direction of the
magnetic field. The letter R in MRI stands for resonance, which is the delivery of radio
frequencies (RF) at the Larmor frequency. The Larmor frequency is the frequency value needed
to stimulate aligned spin vectors in a given region. In other words, the Larmor frequency is the
frequency value of the atomic nuclei for a hydrogen atom at a particular magnetic amplitude.
Lastly, the letter I in MRI stands for imaging. Imaging for an MRI scanner requires an alteration
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of the magnetic field strength over space. This can be done by turning the coils on and off.
Acquired signals are used within Discrete Signal Processing (DSP) cards to reconstruct the
incoming signals from the X – Y – Z planes to create a 3D image of the target tissue that is
being scanned (Huettel et al., 2014).
MRI scanners use pulse sequences to control the timing of signal excitation and data
collection and to generate images from biological tissues. The pulse sequence is a feature that
allows an MRI scanner to acquire images with distinct timing to highlight different tissues with
different physical properties. By using different pulse sequences, it is possible to create images
of different biological tissues (bones, tumors, muscles). However, MRI has several limitations,
such as difficulties in scanning patients with claustrophobia, obesity, and/or metal implants
(Huettel et al., 2014). In spite of these limitations, MRI is routinely used for clinical imaging
and remains one of the most popular methods for performing structural imaging.
T1 and T2 relaxation times are used as a means of generating images for brain mapping.
T1 relaxation is used for anatomical images and is the most common technique used to generate
3D structural images of the brain. Anatomical images are also known to be called T1 images if
T1 relaxation is used during generation. T1 relaxation, or T1 recovery time, is the amount of
time spent for a spin vector to get its maximum longitudinal magnetization value after an RF
pulse. In other words, the T1 recovery graph is the longitudinal magnetization value as a
function of time after an RF pulse.
T2 or T2 decay graphs are generated similarly. However, T2 uses the transverse
magnetization value as a function of time. Another value that is important in T2 decay graphs
is T2*. T2* is the decaying sinusoidal signal used in fMRI. Using the T2-weighted MRI
technique, manipulations in blood oxygen can be measured (Ogawa et al., 1990). The gradient
echo approach is often used with different variations to make tissues sensitive to T2* contrast.
T2* can produce blood origination dependent changes and is always shorter than T2. In
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summary, the T2* principle is the foundation for a BOLD contrast. It is the main reason that
fMRI has a high temporal resolution (Huettel et al., 2014).

2.1.2 Functional Magnetic Resonance Imaging Review
The term fMRI, as the name implies, allows us to investigate human brain function for a short
time period. The data is typically sampled every 2 seconds, referred as the repetition time (TR).
fMRI has a high temporal resolution that can measure short-term functional activity changes,
allowing researchers to localize brain activity on a second-by-second basis. Since fMRI also
has high spatial resolution capabilities, fMRI is a powerful tool to investigate brain activity.
Unlike PET, fMRI does not use radiation or isotopes and is non-invasive, allowing patients to
be scanned multiple times. These features are the main reason that made fMRI a popular
investigative tool. Currently, fMRI is one of the most essential and standard investigative
neuroimaging tools that many researchers prefer to use.
fMRI uses Blood Oxygen Level Dependent (BOLD) signal changes to measure
functional activity (Huettel et al., 2014). The blood oxygen level dependent (BOLD) signal,
which is detected with fMRI, shows the changes in deoxyhemoglobin with localized changes
of brain blood flow and blood oxygenation. This shows the underlying neuronal activity by
presuming more oxygen will be used in more active parts of the brain in a mechanism known
as neuro-coupling. There are mainly two kinds of fMRI techniques that are performed: taskbased fMRI (task-fMRI) and resting-state fMRI (rs-fMRI). As the name suggests, task-based
fMRI uses various tasks during the scanning procedure. In task-based studies, a stimulus/task
is presented for a short period of time alternating with periods of control conditions. It is
currently believed that when a subject performs or responds to a task, there is an increase in
neuronal firing in specific regions of the brain. These increased neuronal firings result in an
increased consumption of blood oxygenation, leading to vasodilation. The increased blood flow
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results in more oxygenated red blood cells than is needed, and the difference between
oxygenated red blood cells and deoxygenated red blood cells results in signal increases in
regions associated with the task. On the other hand, rs-fMRI checks for functional activity in
the brain while the subject is resting. In other words, no specific task scans are acquired in rsfMRI, and the subjects are simply instructed to rest (Huettel et al., 2014, Purves et al, 2011,
Heeger & Ress, 2002).
In terms of rs-fMRI, functional connectivity refers to the synchronization of brain
regions that can form resting-state networks. In other words, functional connectivity is the
common activity of spatially separated regions of the brain. These regions that have common
or synchronized activity create resting state networks such as Default Mode Network, Medical
Visual, Medial Temporal, etc. With this technique, it is possible to identify linked locations
within the brain without the need for a physical connection between the brain regions. Usually,
fMRI images have a 3 mm spatial resolution. This value is lower than T1 images. Furthermore,
fMRI images are overlaid on the T1 images to help with the identification of brain regions in
terms of structure (Lee et al., 2013).
Although MRI and fMRI both use the same principles and the same scanner, they are not
the same. The main difference between fMRI and MRI for neuroimaging is that fMRI provides
information about functional activity in the brain as a function of time. In contrast, MRI
provides structural information about the brain. In other words, MRI scans provide anatomical
scans of the brain, while fMRI scans provide information on the metabolic function of the brain
(Huettel et al., 2014). Furthermore, fMRI provides functional information about the brain as
well as how, when, and where a particular brain function occurred. It can also link various brain
networks and their relation, or functional connectivity, with other networks.
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2.1.3 Blood Oxygen Level Dependent (BOLD) Signals
Increased metabolic activity in a brain region, as reflected in an fMRI scan, implies that neurons
in that region are active. Active neurons use more energy to be able to do their work, and more
energy means more oxygen consumption. For neurons to be able to consume more oxygen for
energy, there needs to be more oxygen in the area. Therefore, the need for oxygen to be used
for energy affects neighboring blood vessels in the region to create increased oxygenated blood
flow to that region. In summary, when there is increased metabolic activity at a brain region,
the amount of blood flow increases as a result of glucose breakdown (Ogawa et al., 1990, Biswal
et al., 1997, Huettel et al., 2014).
Deoxygenated blood is visible with gradient-echo imaging. Gradient echo imaging uses
free induction decay (FID) signals. FID is a short-lived sinusoidal signal that comes from the
spin vectors after a 90-degree radiofrequency pulse. Every tissue characteristic of the FID signal
will be different; thus, the incoming signal will be different. Differences in FID signals allow
for the separation of different tissue types from each other. In summary, deoxygenated blood is
a natural contrast that can be visualized with gradient-echo imaging using MRI. The concept
used in FID signals also led to the creation of the concept of the BOLD signal (Ogawa et al.,
1990, Huettel et al., 2014). The BOLD signal is a metabolic signal, and changes in the ratio of
oxyhemoglobin to deoxyhemoglobin are measured and can be linked to changes in neural
activity (Azeez, 2019, Ogawa et al., 1990).
The response of a neuron is much faster than the BOLD signal itself. Although
indirectly, the BOLD signal response effect is from the firing of nerve cells. The hemodynamic
response function (HRF) explains the changes in cerebral blood flow, oxygenation, and volume.
BOLD signals are defined using HRF with fMRI. In other words, oxygenated blood gets
converted to deoxygenated blood. Moreover, when neurons become active (when neuronal
firing occurs), blood flow increases and results in increased oxygenated blood to that location.
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This process leads to a high-intensity response from the location of the scanned area that can
be seen with fMRI (Ogawa et al., 1990, Boynton et al., 1996, Cohen, 1997).
BOLD signal contrast depends on the amount of blood with deoxygenated hemoglobin,
which will consume the present oxygen, within the brain region. The changes that happen in
the BOLD signal are called HRF, and the fMRI modality is based on that principle. The BOLD
signal can be seen with task-based fMRI research. Task-based fMRI (task-fMRI) is where
subjects perform specific tasks during the fMRI scan, like finger tapping. Resting-State fMRI
(rs-fMRI) checks for neurologic processes that occur without the need for tasks and, unlike
task-fMRI, does not limit the experimental design or the number of questions that can be
answered with the technique (Azeez, 2019, Huettel et al., 2014).
Furthermore, fMRI has a high temporal resolution, which is around 500 milliseconds to
3000 milliseconds (ms). Generally, a stimulus takes about 10 seconds, enough to able to see the
neuronal activation as a function of HRF. A temporal resolution of 500 to 3000 ms (TR value)
is good enough to answer most research questions. In resting state, frequency characteristics of
neuronal activity within the BOLD signal can be seen under 0.1 Hz. However, the BOLD signal
has components both above and below 0.1 Hz. The effects of respiratory and cardiac response
on the BOLD signal can be seen in frequency values higher than 0.1 Hz. Generally, the
elimination of these non-neuronal effects from the BOLD signal in rs-fMRI studies is needed.
Therefore, band pass filtering is typically used. Generally, the low cutoff frequency equals to
0.01 Hz (to eliminate small frequency noise from various sources) and the high cutoff frequency
value is 0.1 Hz, as mentioned earlier (Biswal et al., 1995, Glover, 2011). The reduction of noise
and removal of non-neuronal signals in this study will be explained in more detail within
Chapter 3.
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2.1.4 Application of Functional Magnetic Resonance Imaging
Neuroimaging has had a crucial role in AD studies for the past four decades with different
modalities such as computed tomography or MRI. More recently, structural and functional MRI
showed significant changes in the brains of AD patients. No single neuroimaging modality can
produce every possible image of other neuroimaging techniques, but they all have their uses
and weaknesses. With AD, it is not always clear to make a clinical diagnosis without the use of
neuroimaging; for a definitive diagnosis, neuroimaging is needed (Smitha et al., 2017).
In terms of structural imaging, MRI can detect progressing atrophy (volume), and the
brains of AD patients can have vascular damage that will alter incoming MRI signals for the
T2 images for some sequences. Progression of AD can be identified by checking cerebral
atrophy in the brain, which starts early in AD. Atrophy first manifests itself in the medial
temporal lobe, which is the first sign of AD. Because of this, atrophy of the medial temporal
lobe is considered to be one of the biomarkers in AD that can be detected with structural MRI
(Johnson et al., 2012, Smitha et al., 2017).
In terms of functional imaging, fMRI is a fairly new method when compared to
structural MRI. Brain networks related with memory and other cognitive functions of AD
patients are getting increasingly investigated with fMRI. Both task-fMRI and rs-fMRI give
information about functional connectivity within the brain networks of an AD patient and can
be useful in early detection of AD. Although fMRI has potential for this, a relatively smaller
number of studies are published that are made with AD patients. There are some studies that
reported a decrease in the medial temporal lobe in patients with mild cognitive impairment
(MCI). Recently there is some increase on studies with BOLD fMRI techniques and
spontaneous brain activity with rs-fMRI on AD patients. Especially in terms of pharmacology,
fMRI might be the best way to monitor cognitive function in AD patients. Furthermore,
longitudinal studies are needed to make sense of the fMRI activation patterns. Currently, the
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focus is on characterization of vascular and metabolic features in brains of patients with AD
(Lajoie et al., 2017, Johnson et al., 2012, Smitha et al., 2017).

2.1.5 Limitations of fMRI
The temporal resolution in fMRI, which can be achieved by the high scanning speed of the
modality, needs larger voxel sizes to maintain the required level of signal to noise ratio (SNR).
For this reason, fMRI has increased temporal resolution and decreased spatial resolution from
the generated images. The limit for temporal resolution in fMRI is set by the BOLD signal. As
it is not possible to increase the speed of neuronal responses, and BOLD signals are generated
from the neuronal responses, maximum temporal resolution is dependent on the BOLD signal
(Huettel et al., 2014, Poldrack et al., 2011).
One of the significant challenges of fMRI is head motion during the scan. Patients often
move during scanning, and in most cases the patient’s head motion during the scan cannot be
avoided. This issue would be a huge problem since AD patients might have conditions that may
make them less compliant, such as mood swings or short-term memory problems. Because of
the compliance issues, head motion effects would be problematic for both rs-fMRI and taskfMRI. However, there are methods to be used during the scan and algorithms in pre-processing
steps that can eliminate the effects of head motion. In some cases, head motion can be corrected
for after pre-processing fMRI images, allowing further analysis to be performed (Huettel et al.,
2014, Poldrack et al., 2011).
In fMRI, like PET, patients with claustrophobia may face challenges, since fMRI
imaging requires patients to be in a tight and enclosed space during the scanning time. fMRI is
based on magnetic force, so patients with metal implants or some metal-based tattoos cannot
be scanned with fMRI, thereby presenting an additional limitation to the use of fMRI as a
neuroimaging technique. This also applies for some patients with pacemakers (Basil et al.,
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2018). Lately, there are productions of MRI compatible pacemakers that will enable patients
with these pacemakers to be allowed for fMRI scans. Also, patients with obesity may not be
compatible for fMRI if their measurements are more than what the machine can handle (Huettel
et al., 2014, Poldrack et al., 2011).
Lastly, the scan time is another factor that limits fMRI studies. Generally, a fMRI scan
takes between 2-12 minutes. Individual time points are not independent in terms of statistics in
BOLD signals. Since they are not statistically independent for each fMRI scan, the correlation
value must be corrected for degrees of freedom to determine significance. In short scans,
estimating significance becomes problematic because of a low number of time points available.
To fix this issue, scanning time higher than 5 minutes is needed to allow detection of most
studied networks such as the default mode network. Furthermore, increasing the time decreases
the noise and increases the correlation strength, but may not be necessary. Increasing the
scanning time might cause more head motion or discomfort to the patient so the optimal
scanning time of 5-6 minutes appears to be sufficient for most studies (Van Dijk et al., 2010).

2.2 Data Acquisition
This study was performed on a public dataset from “Alzheimer’s Disease Neuroimaging
Initiative” (http://adni.loni.usc.edu/). MRI and fMRI techniques were used to acquire
anatomical and functional images for each subject. The subjects of this study included both
healthy controls and patients with Alzheimer’s disease. T1-weighted images were acquired
using both 1.5T and 3T MRI scanners at different sites and the spatial resolutions of the
anatomical images were 1x1x1.2 mm3. All fMRI images were acquired with 3T Philips MRI
scanners. Parameters of fMRI scans: TR (repetition time) = 3000 ms, TE (echo time) = 30 ms,
flip angle = 80o, matrix = 64 x 64, slices =15 and, voxel size = 3.3125x3.3125x3.313 mm3.
There were 140 time points for each scan and length of the scans were 7 min long. With the
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fMRI scans date-time of the scan, age of the subject, condition of the subject (Healthy Control
or Alzheimer’s disease patient), and sex information were available this dataset. As reflected in
the public data set, there were different numbers of scans for each subject acquired at different
dates.
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CHAPTER 3

PRE-PROCESSING METHODS
In this section, the pre-processing methods are described with a focus on the methods used in
the current study. Additionally, the definitions of each of these processes and the importance of
these functions are presented. fMRI applies a series of set algorithms on the obtained dataset.
In this model, it is often necessary to eliminate white noise in the data to improve the signal to
noise ratio. The process of eliminating noise and unnecessary data from CSF and large
ventricles is regarded as pre-processing. Also, the fMRI data is transformed to a standardized
space to make the comparison between 2 or more brain scans possible. The pre-processing
pipeline may differ for each study but is generally initiated with the realignment of the
functional images.
During this phase, additional steps are often needed before realignment depending on
the dataset. These can include reorienting functional and anatomical images. The preprocessing pipeline of realignment, coregistration, segmentation, normalization, temporal
regression, and filtration is applied across all the subjects within the dataset. To increase the
efficiency of pre-processing, scripts are provided in standard software programs, which can be
run in a batch from the Statistical Parametric Mapping software SPM12 (Friston et al., 1994)
in MATLAB (Higham & Higham, 2016). AFNI (Cox, 1996) and MATLAB were used in this
study for both pre-processing and data analysis. To provide a more comprehensive review of
pre-processing, the following sections will discuss the individual steps.

Pre-processing steps. In this section, the steps taken before statistical analysis is presented.
Pre-processing is applied to make sure all the data is in the same orientation, corrected for head
motion-induced signal changes, and transformed into the MNI space for future statistical
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analysis. These steps are required to achieve statistically significant results. In this study, the
pre-processing is carried out as follows:
1. Realignment of functional images,
2. Coregistration of functional images to anatomical images,
3. Segmentation of the anatomical images,
4. Normalization of functional images to the MNI space from subject space,
5. Creation of tissue masks from segmented files of anatomical images,
6. Extraction of information from white matter (WM) and cerebral spinal fluid (CSF),
7. Temporal regression using motion parameters and information form WM and CSF, and
8. Bandpass filtration of signals to 0.01 – 0.1 Hz band.

Figure 3.1 Raw fMRI image of an anonymous subject from the current study in the native space
(left to right: axial – sagittal – coronal view).
Source: http://adni.loni.usc.edu/.

3.1 Realignment
The first step of pre-processing is realignment. Realignment step is standard step for fMRI
images to minimize the effects of head motion. This process is necessary as it is not possible to
ensure complete stillness during the scanning process. However, patient movement can produce
false-positive results within the fMRI data of that subject. Realignment attempts to align all the
time points in a fMRI time series. This is necessary because some of the time points in an image
time-series may not have a proper alignment to a reference image, and the reference image
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could be any of the time points within a functional scan or the mean of all the time points within
a scan (Hafiz, 2017). Thus, all the images must align with each other to ensure all errors are
corrected for in the final analysis (Friston et al., 1996, Poldrack et al., 2011).
For this process, the motion correction algorithm uses a least-squares method with a sixparameter rigid body transformation (Friston et al., 1995) representing three rotational (pitch,
roll, yaw) and three translation (x, y, z) parameters. In realignment, a file with information on
these six parameters is generated to further minimize any motion-related artifacts (Hafiz, 2017).
After realignment, the images are resliced such that they match the first image selected voxelfor-voxel to deal with signal discrepancies before normalization. The realignment for this study
has been performed using SPM12.

Figure 3.2 Realignment output of a single fMRI scan from the study

3.2 Coregistration
The coregistration process consists of aligning and overlaying the fMRI data on the anatomical
image. To be able to use these images together, they need to have the same coordination with
each other. Coregistration is used to align the head-motion-corrected fMRI images towards the
inputted anatomical images to ensure the alignment of anatomical and fMRI images. In other
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words, the corrected images are aligned with the anatomical image to allow for an accurate
spatial fit.
The main reason for registering fMRI images to anatomical images is to allow SPM12
to identify the regions of the brain since anatomical images have much better spatial resolution.
Furthermore, the high-resolution quality of anatomical images increases efficacy for assessing
brain locations of fMRI scans of each brain. Through coregistration, viewing the functional
information regarding the brain is improved due to the correlation with anatomical and highquality spatial data. As such, this model was also employed in this study.
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Figure 3.3 Coregistration output of a single fMRI scan from the study.
Source: http://adni.loni.usc.edu/.
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3.3 Segmentation
After coregistration is complete, the next step in the pre-processing pipeline is segmentation.
Segmentation is the process that partitions the anatomical (or functional) image into different
tissue classes. Segmentation is critical due to the integral human brain anatomy. The human
brain is classified within three different tissue types, (1) gray matter (GM), (2) white matter
(WM), and (3) cerebrospinal fluid (CSF). Thus, segmentation is critical to ensure that the
anatomical skull categorizes the separation of the brain tissue. Each anatomical brain image is
used for each patient. Figures 3.4 and 3.5 illustrate the process of segmentation for this study.
In this process, intensity differences in the anatomical MRI images are used. When using
SPM12, a series of 6 differing tissue types are generated. These tissues are GM, WM, CSF,
skull, soft tissue, and remaining parts of the scan (the outside region). It is also essential to
consider the bias information. In this model, bias field estimation and correction is the
normalization of values for different tissue types in the brain. Correction for the
inhomogeneities dramatically increases the accuracy of the segmentation process. SPM12 does
all of this in a single step. WM and CSF tissue classes are used to generate masks for further
steps along the pre-processing pipeline.
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Figure 3.4 White matter output of segmentation of a single anatomical scan from the study in
MNI space (top) & generated mask using 0.98 as the threshold value (bottom).

Figure 3.5 Cerebral spinal fluid output of segmentation of a single anatomical scan from the
study in MNI space (Top) & generated mask using 0.98 as the threshold value (bottom).

22

3.4 Normalization
The process of normalization includes transforming every image into a generic template, such
as the MNI template, that can be applied to all fMRI images. In this process, images from each
of the subjects are transformed into a standardized space so that all images for every subject
will have the same coordinate system and can be processed for statistical analysis. This step is
vital for group-level analysis. As mentioned earlier, all functional images are in their
native space, and every native space is different from that of other native spaces. Thus, each
patient's brain size and shapes are different, and it is necessary to ensure that these different
shapes are in a normalized space for future analysis. For batched or group-level analysis, images
must be in a standard space. The process of normalization warps each patient's brain size and
shape into a standardized brain model that ensures that the spatial fit of all brains are the same.
Thus, the coordinates for comparison between brains is possible through this process of
normalization. The most common standardized space templates are the Montreal Neurological
Institute (MNI) space and the Talairach Space.
For this study, the MNI152 space was used for transformation (figure 3.6). The MNI152
template was created from 152 brain scans of a young adult. SPM12 requires both anatomical
images and fMRI images of each patient to perform transformation of images from native space
to MNI152 space.
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Figure 3.6 Differences between outputs after coregistration (top) and normalization (bottom)
of a single scan from the study into MNI space.

3.5 Nuisance Regression and Temporal Filtering
For this study, PCA was used for assessing correlated components within the fMRI data to
perform nuisance regression. PCA also assesses voxels synced with each other in specific
regions within the fMRI data. Thus, the principal components or eigenvectors (e.g., a value
different than zero) of the covariance matrix of the fMRI data was identified. After the
normalization step in the pre-processing pipeline, WM and CSF images from segmentation are
used to create masks. The masks were generated using 0.98 threshold values of the segmented
images of WM and CSF and resampled to the voxel size of the functional images. A PCA of
5th degree was run on the fMRI data using the respective WM and CSF mask for each individual
subject. Doing this allowed synced voxels within WM and CSF in the brain regions to be
gathered in a single covariance matrix. These generated values include data from the WM and
CSF regions, and since the point of interest is the data from GM, linear regression of these
generated WM and CSF values were made in the regression step. This would allow exclusion
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of the effects of WM and CSF that we would see from the group analysis of the data. PCA had
been done on the functional scans with MATLAB to be used in the temporal regression step
(Hafiz, 2017).
As noted, regression is used to get rid of effects from WM and CSF. Furthermore,
motion parameters from the realignment step were also regressed out from the fMRI scans.
Both extracted values from PCA and 24 motion parameters (six motion parameters, derivatives
of each motion parameter, forward derivatives of each motion parameter, as well as squared
forward derivatives of each motion parameter) were used in the regression step. In other words,
a total of 34 regressors were used in the regression step. To regress out these 34 regressors from
the fMRI scans, MATLAB was used. First, ten time-points of the time series of the fMRI scans
were removed to avoid false-positive results, which can be caused by the scanning process's
adaptation period at the start of the procedure (Azeez & Biswal, 2017, Hafiz, 2017). After
temporal regression, a bandpass temporal filter in the range of 0.01-0.1Hz was applied to all
time series, to remove any physiological noise and other artifacts using AFNI. This is a standard
process for rs-fMRI research (Biswal et al., 1995, Hafiz, 2017).
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Figure 3.7 Signal differences in the hippocampus between normalized fMRI image (top 9
graphs) & filtered and regressed fMRI image (bottom 9 Graphs) for a single fMRI scan from
the study.

3.6 Smoothing
For the last step of pre-processing, spatial smoothing was used to increase the signal to noise to
noise ratio. A 6mm full width at half maximum (FWHM) filter was used for smoothing. The 6
mm FWHM was used because the voxel size of the normalized fMRI images was 3mm. For
best results, twice the voxel size number of the fMRI image must be used as the FWHM value.
Also, for certain data sets with enough samples, it is crucial to use a minimum FWHM value
(Poldrack et al., 2011).
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Figure 3.8 Differences between outputs after filtration (top) and smoothing (bottom) of a
single scan from the study.
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CHAPTER 4
FUNCTIONAL CONNECTIVITY AND STATISTICAL ANALYSIS

Functional connectivity is the temporal correlation of 2 or more neurophysiological signals at
spatially different locations in the brain. These events can be analyzed either in the time or
frequency domain. Temporal analysis can provide information about the changes within a given
time series in an fMRI dataset. Frequency analysis can provide information about the frequency
content of the events that are happening in a particular fMRI dataset. These techniques can also
be designated into either a model-driven or a data-driven analysis. Each model can include
either frequency analysis or temporal analysis methods. Model-driven methods are useful when
there is some prior information about the current dataset and research topic, while data-based
methods make no such assumptions and finds the areas of interest according to the fMRI data
provided. In this study, data-driven methods are mostly used, and the only model-driven
approach would be the three regions that were identified from the Independent Component
Analysis (ICA) (Azeez & Biswal, 2017, Buckner et al., 2013, Chen et al., 2020, Friston, 1994).

Table 4.1 Methods Used For This Study

Methods
Temporal
Frequency

Data-Driven
ICA, ReHo
ALFF, mALFF, fALFF

After the completion of the various analyses, the results were inputted into a multiple
linear regression model to find their significance in terms of P-values, as explained in section
4.3. Furthermore, the effects of age and gender were evaluated and explained in Section 4.4.
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4.1 Temporal Domain Methods
4.1.1 Independent Component Analysis (ICA)
ICA is a popular data-driven method in neuroimaging. ICA is a method like PCA with a crucial
difference: while the PCA method estimates components that are orthogonal, ICA generates
components that are independent of each other. PCA cannot accomplish this because it assumes
a Gaussian distribution (Azeez, 2019, Azeez & Biswal, 2017, Hafiz, 2017). With ICA, we
obtain independent components for the fMRI images. This means that for the rs-fMRI data, we
can see the resting state networks from the analysis. From the spatial maps, there is a challenge
in linking these spatial maps to neurological function. It is also a way of confirming the quality
of the data and preprocessing. Generally, after ICA for rs-fMRI data, there is a certain number
of resting state networks that a researcher expects to see (Azeez & Biswal, 2017, Calhoun et
al., 2003, Chen et al., 2008, Smitha et al., 2017).
For this study, a group ICA was applied to the dataset after the pre-processing procedure.
Group ICA was performed using the MELODIC feature from FSL (the FMRIB Software
Library) (Jenkinson et al., 2012). Three sessions were made using 20, 25, and 30 component
ICA. The reason for these choices was to achieve the best ICA components while avoiding a
mixture of components to form (Beckmann et al., 2005). In the 20 component ICA, some resting
state networks that needed to be separate were mixed into a single spatial map. With the 30
component ICA, some resting state networks that needed to be a single spatial map were
separated into multiple maps. The best results were acquired using a 25 components ICA. From
the 25 component ICA analysis, 3 probability maps were used to create masks with the SPM12
image calculator to be used in further steps of the analysis. For the masks, a threshold value of
0.95 was used.
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Figure 4.1 Resting state networks generated from group independent component analysis.
A. aDMN (anterior default mode network), B. CN (cerebellar network), C. DA (dorsal
attention), D. DMN (default mode network), E. dSM (dorsal sensory motor), F. FC (frontal
cortical), G. LFP (left frontoparietal), H. LV (lateral visual), I. MT (medial temporal), J. MV
(medial visual), K. RFP (right frontoparietal), L. VS (ventral stream), M. vSM (ventral
sensory motor) (sagittal – coronal – axial view).

4.1.2 Regional Homogeneity (ReHo)
Regional Homogeneity, also known as ReHo, is another data-driven approach. This method
applies a voxel by voxel approach to map underlying connectivity activations within the brain.
As the name suggests, ReHo finds the average correlation with its neighboring voxels for every
voxel in the brain. To check for the correlation between voxels, Kendall’s correlation
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coefficient (KKC) is used in conjunction with the size of the clusters (Zang et al., 2004). ReHo
is considered to be a robust method against noise but is still susceptible to signal artifacts and
can cause false positive results. Local functional connectivity is the synchronized response of a
BOLD time series for the functional activations in a given 10-15 mm region. Based on the
hypothesis of significant brain function, these 27 voxels or 10-15 mm area are active in a form
of cluster rather than a single voxel. (Azeez & Biswal, 2017, Bayram et al., 2018, He et al.,
2007, Jiang & Zuo, 2016, Liu et al., 2008).
In this study, the masks created from the probability maps acquired from group ICA
analysis are used on the ReHo maps. The ReHo spatial maps are generated using AFNI. Outputs
of temporal regression and filtration were used to generate ReHo spatial maps. Using the masks
on the spatial maps, the mean value for each fMRI scan were calculated using MATLAB to be
used later in multiple linear regression analysis (Di et al., 2019). Lastly, outputs of ReHo were
smoothed using SPM12.

Figure 4.2 Regional homogeneity of an anonymous subject from the current study overlaid on
MNI template (axial – sagittal – coronal view).
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4.2 Frequency Domain Methods
4.2.1 Amplitude of Low Frequency Fluctuations (ALFF)
In rs-fMRI, functional connectivity is highly correlated with low frequency fluctuations. ALFF
presumes that all neurological activity in a BOLD signal from rs-fMRI can be shown with a
singular parameter. In short, it takes the square root of the power of BOLD signals in 0.01-0.1
Hz range and sums it up to obtain the ALFF value. This method is sensitive to noise sources;
hence, quality and preprocessing of the raw data plays an important role in ALFF. Because
ALFF might have noisy signals, there will be a higher probability of a large ALFF value. An
alternative method called fractional ALFF (fALFF) can also be used. In fALFF, the ALFF value
is divided by the spectral power for the entire power spectrum. This method also may produce
low quality spatial maps caused by low quality in fMRI scans, but it may produce significant
results when provided with quality rs-fMRI scans (Zou et al., 2008). Another version is the
global mean ALFF (mALFF). In mALFF, as the name suggests, each voxel in ALFF gets
divided by the global mean of ALFF (Yang et al., 2019, Fox & Raichle, 2007).
The masks created from the probability maps acquired from group ICA analysis are
used on the ALFF, fALFF, and mALFF maps (figure 4.4). These spatial maps are generated
using AFNI. Outputs of temporal regression were used to generate ReHo spatial maps. Using
the masks on the spatial maps, the mean value of each fMRI scan and each spatial map were
calculated using MATLAB to be later used in the multiple linear regression analysis (Di et al.,
2019). Lastly, all ALFF, fALFF, and mALFF outputs were smoothed using SPM12.
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Figure 4.3 ALFF (top), mALFF (middle), fALFF (bottom) of an anonymous subject from the
current study overlaid on MNI template (Axial – Sagittal – Coronal view).

4.3 Multiple Linear Regression Analysis
In this study, all the spatial maps from ALFF, mALFF, fALFF, and ReHo are used with 3 masks
generated from the probability maps from ICA to get individual mean values for specific
regions. The regions used are the Default Mode Network (DMN), the Medial Visual Network
(MV), and the Medial Temporal Network (MT). A value, or score, is generated for each spatial
map and used within the multiple linear regression analysis. Other than the ALFF, fALFF,
mALFF, and ReHo score, the age of the subjects and category (AD or HC) of the subjects are
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also used in the equation. R Commander was used to do these calculations (Fox & BouchetValat, 2020).

Figure 4.4 Formula used for multiple linear regression analysis.

As can be seen from the formula (figure 4.5), both predictors X1 and X2 create a third predictor
by multiplication. In other words, the third coefficient is influenced by the first two predictors.
Even if the P value of one of the first two predictors is not significant, it may still be significant
for the third feature. Similarly, if the first two features are significant, there is no guarantee that
the third feature will be significant. This is called the hierarchical principle, and it basically
means that two non-significant individual models could have significance when they interact.
For this study, our predictors are age of the patients and the group they are in (HC or AD).

4.4 Statistical Analysis of the Participants
In the study, some subjects were removed due to several reasons. These reasons were: high
motion that cannot be corrected, corrupted/missing rs-fMRI or anatomical images, and
incompatible number of time points. Following the removal, the Shapiro-Wilk and ShapiroFrancia Normality Test, the Levene’s Homogeneity Test, and a two-sample t-test had been
performed for age. For gender, the Chi-squared test had been performed. In the study, there are
61 individuals (33 are female and 28 are male). The age range of the participants is 56 to 91.
The mean of these ages is 74.4721 and standard deviation is 7.0408 (figure 4.6).
The P value of the Shapiro-Wilk and Shapiro-Francia Normality Test was 0.6663, which
indicates that normality was met. The P value of the Levene’s Homogeneity Test was 0.6836,
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which means homogeneity was met. The P value of the Two Sample T-Test was 0.1129, which
means age should not affect the analysis. Similarly, the P value of the Chi-Square test was
0.9061, which means gender should not affect the analysis.

Figure 4.5 Age distribution of the participants (x – axis: age, y – axis: quantity).
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CHAPTER 5
RESULTS

This chapter will focus on the results obtained in this study. After preprocessing, there were 76
scans for AD and 79 scans for HC, adding up to a total number of 155 scans used within the
study. Voxel-wise functional connectivity parameters were obtained using several methods,
including ICA, ReHo, ALFF, mALFF, and fALFF. Spatial component maps were generated
using ICA. Voxel wise parameters from each of the spatial maps were obtained using ReHo,
ALFF, mALFF, and fALFF. Twelve different scores were generated from the dataset using the
twelve plots made from the score, age, and category of the subjects. From the 12-score set, 6 of
them (mALFF and ReHo) matched the results of previous studies, and the other 6 (ALFF and
fALFF) were in low quality caused by low-quality scans (high head motion). Thus, spatial maps
from ALFF and fALFF were not able to be used for further analysis. The six score sets that
were acceptable were used to do a multiple linear regression analysis. For the analysis, every
scan was presumed to be from a different subject even if several scans were taken from the
same patient.

5.1 Region of Interests
After preprocessing, a group ICA was performed using data from all 155 individual scans. A
total of 13 meaningful resting-state networks were determined from ICA, as shown in figure
4.1 (Calhoun et al., 2003, Beckmann et al., 2005). From the probability maps generated with
ICA, three maps were chosen to use as ROIs (figure 5.1). These ROIs were created by
thresholding the probability maps. Selection of ROIs was done according to previously
published literature.
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In previous studies, it has been showed that the MT is one of the regions that gets
affected from AD. Furthermore, it has been shown in functional brain imaging that these
abnormalities occur before atrophy starts to present itself in the early stages of AD (Grajski &
Bressler, 2019, Qi et al., 2018). The hippocampus in the MT is involved with memory, and
memory loss is one of the major symptoms that AD patients suffer from. Subsystems which
deal with memory are also linked to the DMN, which suggests that the FC of DMN also gets
affected (Qi et al., 2018). Because of this dilemma, it is expected to see decreased FC in the
MT caused by the WM atrophy in AD patients (Berron et al., 2020), which is an easy symptom
to miss in early stages of the disease with only a physical examination. The MT shows potential
to be used as a neuroimaging biomarker for early detection of AD, which is also supported by
metabolic abnormalities that can be seen within the network (Mevel et al., 2011, Greicius et al.,
2004, Ridha et al., 2007).
The DMN is a network that is connected to various regions within the brain and is one
of the regions that has high potential to be used as a neuroimaging biomarker for early detection
of AD (Badhwar et al., 2017). FC changes in the DMN are highly corelated with AD, especially
in the precuneus (PCC) (Mevel et al., 2011). Connectivity between the PCC and hippocampus
suggests that the DMN could also be a potential neuroimaging marker for early AD detection
(Mevel et al., 2011). Although the DMN is a region that is highly used to separate HCs from
AD patients, the diagnostic power of the DMN as a neuroimaging biomarker is yet to be seen
because of high baseline FC of certain regions within the DMN (Koch et al., 2012). Past studies
also show that though there were no statistical difference between HCs and mild cognitive
impairment (MCI) patients, there were similarities at the PCC of the DMN (Wu et al., 2011,
Yu et al., 2016). Furthermore, past studies show that MMSE values of AD patients seem to be
linked with FC decreases within the DMN in AD patients, possibly strengthening the diagnostic
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power of DMN as a neuroimaging biomarker (Buckner et al., 2008, Sorg et al., 2007, Wu et al.,
2011).
Visual performance also decreases with AD, which suggests that the primary visual
cortex could show FC differences in patients with the disorder (Armstrong,1996, Mendez et al.,
1990, Leuba & Kraftsik, 1994, Yamasaki et al., 2019). Nevertheless, there are some
controversies about this, since only some clinical studies show visual performance differences
between AD and MCI patients when compared with HCs (Armstrong, 2009). It is also important
to consider any other conditions that may impact the patient’s eyesight before using visual
performance as a parameter to differentiate HCs from AD and MCI patients. Since it is difficult
to determine the primary reason for an impaired visual performance, FC differences between
HCs and AD patients in the primary visual or the MV network can be a potential neuroimaging
biomarker. Previous studies showed markers linked to AD were found not only within the
primary visual cortex, but also on certain components of the eyes itself (Armstrong, 1996,
Beach & McGeer, 1992, Ikonomovic et al., 2005, Kusne et al., 2017). While clinical tests show
abnormalities in terms of visual function in both AD and MCI patients, there are not many rsfMRI and FC studies performed about this region (Cerquera-Jaramillo et al., 2018, Kusne et al.,
2017). Overall, the MV network shows potential to be a neuroimaging biomarker for AD, and
is also one of the ROIs that has been investigated within this study (Bokde et al., 2006).
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Figure 5.1 ROIs created from probability maps acquired from ICA. DMN (top), MT (middle),
MV (bottom) (axial – coronal – sagittal).

5.2 Local Activity
As mentioned earlier, three ROIs were used: DMN, MV, and MT. For each of the three resting
state networks, we also generated mALFF and ReHo scores on a voxel-wise basis. By doing
this, six scores were generated for each scan. These scores were: DMN-mALFF, DMN-ReHo,
MT-mALFF, MT-ReHo, MV-mALFF, MV-ReHo. By using these scores as the y-axis and the
current age of the subject as the x-axis for every 155 scans, their plots were generated according
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to their groups (AD or HC). For each graph and each data point in the graphs, linear regression
was used to determine the relationship between the two parameters in the graph. Scores were
plotted as a function of age (Di et al., 2019).

5.2.1 Local Activity Differences for DMN
Figure 5.2 and Figure 5.3 show local activity differences in the DMN region from the mALFF
and ReHo measures. In various studies, it has been shown that the DMN region has a role in
AD (Mevel et al., 2011, Koch et al., 2012). The DMN has a major role in rs-fMRI studies and
is a widely studied brain network in the neuroimaging world. The DMN is known to have highlevel metabolic activity during the passive state. This means that for rs-fMRI scans, the DMN
should have high local and metabolic activity. Also, previous neuroimaging studies made with
spontaneous low-frequency fluctuations and regional homogeneity show that it is linked to
crucial subsystems (Sheline et al., 2010). It links various regions such as the precuneus
cingulate cortex to these subsystems (Wang et al., 2006). Various studies show that impairment
of DMN is a result of AD (Bayram et al., 2018, Marchitelli et al., 2018, Qi et al., 2018).
As can be seen from Figure 5.2 and Figure 5.3, AD patients show decreased local
activity for mALFF and ReHo measures within the DMN region for the dataset used in this
study. From Figure 5.2 and Figure 5.3, we can also see that age has a decreasing effect in the
DMN-mALFF and DMN-ReHo scores. By using the formula from Figure 4.4, a hierarchical
model was used to perform a multiple linear regression analysis to see the effect of age and
condition on the DMN-mALFF and DMN-ReHo scores. The purpose of this longitudinal
analysis is to determine if the decrease in local activity or functional connectivity is different
between HC and AD, and can be explained using age, condition, or both.
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Figure 5.2 DMN-mALFF graph.

Table 5.1 P Values From DMN Of mALFF Graph
P-value of AGE feature

0.000000328

P-value of GROUP feature

0.0377*

P-value of AGExGROUP feature

0.1168

Figure 5.2 illustrates a negative relationship between the dependent variable (mALFF) and the
independent variable (age). The attained P values display a decrease in the dependent variable
and an increase in the independent variable. Therefore, the P-value highlights that age is not a
significant determiner, and that this focus hypothesis was not met (Table 5.1).
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Figure 5.3 DMN-ReHo graph.

Table 5.2 P Values From DMN Of ReHo Graph
P-value of AGE feature

0.00182*

P-value of GROUP feature

0.41757

P-value of AGExGROUP feature

0.73272

In comparison, Figure 5.3 justifies that the DMN-ReHo graph displays a negative relationship
between the variables. However, the results attained were not significant, as the P-values did
not exceed 0.05 for the last two features (Table 5.2). As highlighted before, the DMN includes
the following regions within its boundaries: the posterior cingulate cortex (PCC) or precuneus,
the ventral and dorsal medial prefrontal, the medial temporal lobes, and the lateral parietal
cortices. Furthermore, the posterior cingulate cortex and the hippocampus is impaired in AD in
terms of FC. Other scholarly deductions state that PCC atrophy is a result of long-term effects
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of brain disconnections that further worsen the progression of AD on the patient. Furthermore,
when age is factored in as a variable utilizing the two-sample T-test, a 0.1129 P-value affirmed
that age would not affect the linear regression analysis results.

5.2.2 Local Activity Differences for MT Lobe
Figure 5.4 and Figure 5.5 show local activity differences in the MT region from mALFF and
ReHo measures. Previous studies showed that the MT is affected in the brains of AD patients.
The MT lobe includes the hippocampus and has a vital role in terms of memory. The MT is
responsible for several cognitive and emotional functions. Atrophy of the MT lobe is a common
finding in many studies (Ridha et al., 2007). Furthermore, many PET studies also show that
metabolic activity also differs between HCs and AD patients for the MT lobe (Fischer et al.,
2019, Mevel et al., 2011, Márquez & Yassa, 2019). This suggests that regional brain atrophy
of the MT lobe has a role in the corresponding resting state activity, and AD patients present
symptoms like verbal memory decline, episodic memory decline, visual memory decline,
memory recall delay increase etc. (Mevel et al., 2011, Gilboa et al., 2015, Yamashita et al.,
2019). Also mentioned above, the MT lobe is a subsystem of DMN, which means a local
activation decrease at DMN would also show itself in a local activity decrease at the MT lobe.
In other words, sub-regions of the MT lobe that deals with memory are major locations that get
affected in AD patients. Since MT is a subsystem of DMN, it is logical to presume memory
decline and decreased local resting activity in DMN means a decreased local activity for the
MT lobe (Bayram et al., 2018, Berron et al., 2020, Liu et al., 2008, Rombouts et al., 2005).
As can be seen from Figure 5.4 and Figure 5.5, AD patients show decreased local activity
for mALFF and ReHo measures within the MT lobe region for the dataset used in this study.
However, from Figure 5.4 and Figure 5.5, we can also see that age has a decreasing effect in
MT-mALFF and MT-ReHo scores, just like in the DMN-mALFF and DMN-ReHo scores.
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Using the formula from Figure 4.4, a hierarchical model is used to do a multiple linear
regression analysis to see the effects of age and condition on the MT-mALFF and MT-ReHo
scores.

Figure 5.4 MT-mALFF graph.

Table 5.3 P Values From MT Of mALFF Graph
P-value of AGE feature

0.0733

P-value of GROUP feature

0.1530

P-value of AGExGROUP feature

0.1566
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Figure 5.5 MT-ReHo graph.

Table 5.4 P Values From MT Of ReHo Graph
P-value of AGE feature

0.473

P-value of GROUP feature

0.903

P-value of AGExGROUP feature

0.1566

Figure 5.4 illustrates the relationships between the MT and mALFF, where the dependent
variable was the mALFF of MT while the independent variable was age. In contrast, for the AD
results, the line projects a negative relationship in which when the y-variable increases, the age
variable correlates towards the reduction plane for AD. The P values prove significant in the
context of AD and HC groups, respectively. Studies support that frontotemporal dementia in
young people is the precipitating factor, which is common in people under 65 years (Rossor et
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al., 2010, Rombouts et al., 2005, Smitha et al., 2017, Yetkin et al., 2006). In Figure 5.4 and
Figure 5.5, the P-value hardly meets a 0.05 threshold to be significant (Table 5.3 & Table 5.4).
To check for the correlation between the voxels, Kendall’s correlation coefficient
(KKC) is used. The size of the clusters that are found is around 27 voxels. The method is used
to describe local functional connectivity at a given voxel and its neighboring voxels. Local
functional connectivity refers to the synchronized response of the BOLD time series for
functional activations in each 10-15 mm region. Based on the hypothesis of significant brain
function, these 27 voxels, or 10-15 mm area, happen in the form of a cluster rather than a single
voxel. Figure 5.4 and 5.5 illustrate that in the MT during early AD, FC of the hippocampus
decreases according to HCs.

5.2.3 Local Activity Differences for Primary Visual Network
Figure 5.6 and Figure 5.7 show local activity differences in the MV region from the mALFF
and ReHo measures. Unlike the DMN or MT lobe, the visual cortex has not been as widely
studied in AD patients within the neuroimaging world. It is known that AD also affects the
visual system. Although AD is mostly known to affect cognitive function, there are also known
effects on various sensory functions, such as the visual systems. Visual dysfunctions in AD are
possible neuroimaging biomarkers at the functional level. Nevertheless, there are fairly few
neuroimaging studies done on the visual cortex in AD. AD is known to cause reduced retinal
thickness, retinal vasculature, and quantity of optic nerve axons. Furthermore, visual problems
show themselves in early AD. Some of these are visual acuity, contrast sensitivity, color
discrimination, visual-special perception, the processing speed of visual information, and
visual-spatial attention. Because of all these dysfunctions, it is possible and logical that AD
patients would show decreased local activity in the Medial Visual (MV) network in rs-fMRI
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(Armstrong, 2009, Cerquera-Jaramillo et al., 2018, Kusne et al., 2017, Leuba & Kraftsik, 1994,
Zhang et al., 2009).
As can be seen from Figures 5.6 and 5.7, AD patients show decreased local activity for
mALFF and ReHo measures within the MV lobe region for the dataset used in this study. From
Figure 5.6 and Figure 5.7, we can also see that age has a decreasing effect in MV-mALFF and
MV-ReHo scores, just like in the DMN-mALFF, DMN-ReHo, MT-mALFF, and MT-ReHo
scores. Using the formula from Figure 4.4, a Hierarchical model is used to do a multiple linear
regression analysis to see the effect of age and condition on the MV-mALFF and MV-ReHo
scores.

Figure 5.6 MV-mALFF graph.
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Table 5.5 P Values From MV Of mALFF Graph
P-value of AGE feature

0.00000162 *

P-value of GROUP feature

0.0615

P-value of AGExGROUP feature

0.1191

To investigate brain activity in people with impaired cognitive activity, changes concerning the
brain structure as well as function are of vital concern. Figure 5.6 did not meet a 0.05 threshold
for the last two features (Table 5.5). This implies that the (P<0.0615) value is insignificant.

Figure 5.7 MV-ReHo graph.
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Table 5.6 P Values From MV Of ReHo Graph
P-value of AGE feature

0.00241*

P-value of GROUP feature

0.41471

P-value of AGExGROUP feature

0.56839

ReHo or mALFF of BOLD signals, as delineated in Figure 5.6 and Figure 5.7, have assessed
changes in the resting state occipital cortex of this study’s respondents. Both effects could exist
together in either MCI of AD. The diminished FC in the cuneus/precuneus was considered to
be related to decreased memory execution, and the expanded action could be paying for harm
by the enlistment of different regions such as MV. It is also a known that AD affects atrophy in
WM, which includes visual mechanisms that can cause FC changes in GM at MV. Nevertheless,
the analysis only showed the AGE feature to be statistically relevant.
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CHAPTER 6
DISCUSSION AND CONCLUSION

The current study investigated rs-fMRI scans of AD patients and healthy controls to identify
differences between the two groups. Spatial maps, generated from the rs-fMRI scans of the AD
patients and the HCs and analyzed using several multiple linear regressions, were used to
compare the two groups in a longitudinal approach. The discussion section further examines
the outcomes of this functional connectivity analysis.

6.1 Discussion
This study, although unable to show statistically significant results with the AGExGROUP
feature of the equation, does show expected local activity differences between HCs and AD
patients as a function of age in the patterns within the graphs. The purpose of this study was to
measure local activity differences with a ROI-based hypothesis using the Hierarchical Principle
with rs-fMRI scans. In further studies with a similar approach, and with a more controlled
(stages of the disease) and more quality dataset, it is possible to generate statistically significant
results. The importance of this approach is to be able to identify biomarkers for AD to be used
in popular methods such as machine learning and graph theory (Huf et al., 2014, Khazaee et al.,
2015). In other words, finding potential neuroimaging biomarkers from a detailed and highquantity rs-fMRI AD dataset has potential to be used as diagnostic tools on future patients to
start their treatment as soon as possible. This would help with the diagnosis of the disease, since
it is expected that the number of AD patients will drastically rise in the future. In AD, early
detection and diagnosis of the disorder are generally not easy to make, and late treatment loses
its effectiveness. Furthermore, early symptoms are easy to mix with those of becoming elderly.
This means that symptoms of aging and symptoms of early AD are similar to each other.
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6.1.1 Functional Connectivity (FC)
To begin, the standard longitudinal analysis failed to produce any significant outcomes in this
study. In the current study, the graph displays significance in the DMN and the MV, which
impacts the age variable inversely instead. In contrast, the inter-network functional activity
evolves with age, and the anti-correlated activity between the dorsal attention network and the
DMN also significantly minimizes with age. Past research indicated that reduced FC raised the
hypothesis that cortical hubs, including PCC, are susceptible to functional deterioration as a
result of their relatively high metabolism (Qi et al., 2018), which is no longer maintained due
to amyloid deposition that co-occurs in these hubs (Berron et al., 2020). Despite the consistency
with the literature of the observed FC outcomes pointing out lower connectivity in AD, the
research findings did not indicate reductions in the DMN network that were statistically
significant on a robust level. Some of the main reasons for this could be because: a limited
number of scans since data-driven methods function better with more data; a limited amount of
information about the scans could suggest the possibility that the progression of the disease
might be quite different for each patient; and the quality of the dataset that might have caused
false negative results.

6.1.2 Impairment of DMN is a Result of AD
The results of the mALFF of the DMN indicated that AD patients show decreased local activity
for mALFF as well as ReHo measures within the DMN region for the dataset included in this
study. The relationship between localized neural activity and dynamic connectivity in the two
core regions of the DMN was identified through directionally asymmetric and particularly
specific ROIs: DMN, MV, and MT. AD patients showed decreased local activity for mALFF
and ReHo measures within the MV region for the dataset applied for the current research study.
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However, further analysis indicates that age has a considerable impact, since it has a reducing
impact in MV-mALFF (Page-MV-mALFF =0.00000162) and MV-ReHo (Page- MV-ReHo = 0.00241)
scores similar to the DMN-mALFF (Page-DMN-mALFF = 0.000000328), DMN-ReHo (Page-DMN-ReHo
= 0.00182), MT-mALFF (Page-MT-mALFF = 0.0733), and MT-ReHo (Page-MT-ReHo = 0.473) scores.
As can be seen from the P values in the multiple linear regression analysis of the graphs
(Chapter 5), 4 out of 6 measures were significant for the age feature. Furthermore, group
features of the DMN-mALFF also showed significance with a multiple linear regression
analysis (Pgroup-DMN-mALFF = 0.00377). When investigating rs-fMRI scans of individuals with
impaired brain cognitive activity from the study, a multiple linear regression analysis with the
mALFF and ReHo of 3 ROIs did not show significance for the third feature of the equation
(AGExGROUP). Hence, the p values (P>0.5) are statistically insignificant. Therefore, this
study shows that the hypothesis was not achieved.

6.1.3 DMN in AD Patients
From the study, DMN activity among AD patients is consistent with those found using the PET
measure of resting-state brain metabolism and this shows the significant involvement of the
PCC region for examinations through rs-fMRI scans for AD (Mevel et al., 2011, Marchitelli et
al., 2018). Increments in DMN connectivity or activity have likewise been accounted for in
patients with MCI when contrasted with AD (Gardini et al., 2015, Zhang et al., 2012). Along
these lines, amnestic mild cognitive impairment (aMCI) patients were described by (i)
increments in DMN activity situated inside the PCC/precuneus, (pre)frontal, lateral parietal, as
well as central temporal cortices and (ii) increments in FC between right parietal cortex and left
insula (Ward et al., 2014). Moreover, in AD, resting state activity decreases were found to
involve (i) DMN activity inside the PCC/precuneus, frontal, occipital, parietal, and (pre)frontal
cortices and (ii) DMN activity between left hippocampus – prefrontal, dorsolateral cortex/PCC
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– left frontoparietal cortices (Zhong et al., 2014). These outcomes point to the occurrence of
possible compensatory forms rising in the beginning phases of the infection that are situated in
a few DMN regions (Mevel et al., 2011).
On the other hand, aMCI and AD patients with high cognitive reserves demonstrated
higher movement in task-related brain zones and expanded deactivations inside the DMN
(PCC/precuneus, front cingulate) contrasted with those with low intellectual reserves (SoléPadullés et al., 2009, Yamashita et al., 2019). This more prominent reallocation of handling
assets from the DMN to cerebrum territories legitimately occupied with the test errand could
reflect expanded redesign of useful compensatory assets in patients with high psychological
reserves. To summarize, higher cognitive reserve capacities permit a more-with-less method of
brain function in normal aging and makes up for neurotic procedures as they show up
(Rombouts et al., 2005).
One other objective of the current studies evaluating the impacts of AD on the DMN is
to disentangle biomarkers that might be valuable for the early diagnosis of the disease. The
interruption of the hippocampus or PCC availability could be a decent applicant, as it increases
as the illness progresses. Lower deactivations inside the entire DMN, and particularly inside
(average) parietal territories, were also seen as related to change from aMCI. Furthermore, Koch
et al. proposed that the utilization of multivariate investigations joining proportions of the
movement of explicit DMN zones to proportions of the interconnectivity between these locales
improved the determination precision. Strikingly, utilizing this methodology, the infection
design seen in patients with AD could be distinguished in a great extent from that of aMCI
patients, recommending that such a mix of resting state scans might be appropriate to diagnose
AD at an early stage.
Past studies have given an enlarging backing to a preferential alteration of the parts of
DMN in AD, however. In any case, the purpose behind the prevalent powerlessness of these
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areas stays indistinct. As per Buckner et al., cortical center points might be mainly influenced
in AD considering their persistent high standard movement and related metabolism, which may
prompt expanded helplessness (quite to beta-amyloid testimony). This speculation is backed by
studies demonstrating a connection between amyloid deposition and impaired DMN function
in older individuals without dementia. Further multimodal examinations in all-risk subjects and
AD patients are expected to be even more likely to comprehend this fascinating cover between
the DMN and the dissemination of beta-amyloid testimony inside the brain (Sheline et al.,
2010).
Considering that there are similar trends within the graphs and that there are some
significant results for some of the outcomes of the P-values from the multiple linear regression
analyses, it is possible to say that this study is a positive step to achieve desired results with the
current hypothesis with further research. As pointed out earlier, the DMN contains the
precuneus or PCC. The functional connectivity between the hippocampus (which is in the MT)
and the PCC appeared to be impaired with AD. Following reduction in visual processing areas,
AD patients starts exhibiting memory-induced alterations or decrease in resting state activation
of MT (Golby et al., 2005). The hippocampal atrophy instituted episodic memory and functional
perturbation impairment due to the disruption of the cingulum bundle (Agosta et al., 2012, Sorg
et al., 2007, Wu et al., 2011, Yamasaki et al., 2019, Zhang et al., 2009).

6.2 Conclusion
The results from the current study, although like the results from previous studies, are
statistically insignificant. In other words, none of the results were able to explain the graphs
with the AGExGROUP feature, and only the DMN-mALFF results were able to explain the
GROUP feature. 4 out of 6 measures (DMN-mALFF, DMN-ReHo, MV-mALFF, and MVReHo) were able to explain the graphs with the AGE feature.
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This does not necessarily mean these features cannot be used as biomarkers. There are
multiple reasons why the feature with age and group interaction from the formula was not
significant for the 6 graphs. One of the main reasons is the quality of the fMRI scans. After
realignment, six motion parameters were used to calculate frame displacement values for all
scans. A standard deviation value of 2 was used as a threshold after taking the Z scores of the
motion parameters. Even with 2 as the standard deviation, more than half of the dataset was
excluded because of the high motion within the scans. Furthermore, some subjects had
corrupted fMRI and anatomical scans that had to be removed. Even with the low quality of the
fMRI scans, expected patterns within the graphs were seen.
Total number of 28 scans had to be removed due to following reasons: corrupted
fMRI/T1 scans, inconsistent number of time points in fMRI scans, too many head motion
effects after calculating frame displacement using the 6 motion parameters, and normalization
issues. After the removal of scans, there were a total of 31 HCs and 30 AD patients left after
pre-processing, which had either had single or multiple scans for each subject (total number of
79 scans for HC and 76 scans for AD patients). Because of the data's limitations, a presumption
of accepting each scan as an individual subject was made, but not even this was enough to be
able to generate significance with the equation in Figure 4.4.
Also, the scans were acquired at different sites. This could have caused variability in the
data. Each MRI scanner has a unique noise coming from its components, called the scanner
noise. Like the effects from head motion, this can cause certain values within the scan to elevate
and cause false negative results.
Another reason could be the age range of the groups that might have cause insignificant
results. Differences in the age ranges for each group might have affected the slopes of the
graphs, which might have created insignificant results. For AD patients, this range is between
55 to 88, while for HC it is between 65 to 90. Slopes being affected might have changed the
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pattern of the line generated by the multiple linear regression analysis, thus affecting the
significance of the result.
The last reason for non-significant statistical results could be the absent information of
the data. There was no information about the stage of the disease for each AD patient. This
could have caused variability in the data. This can also be seen in the differences between scores
for patients with the same age and condition, as shown in the generated graphs (Chapter 5).
Overall, resting state functional magnetic resonance imaging as a neuroimaging method has
great potential to increase diagnoses and prognoses of AD. Using the modality and various
analyses techniques, it is possible to find neuroimaging biomarkers for not only AD, but also
other cognitive disorders for early detection. Although there is great potential, future research
needs to be done on the topic.
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